Blinklab: Half Yearly Report and Accounts
Filed with ASX · · 22 pages · English
There have been no gains or losses of control over entities in the half-year ended 31 December 2025. AUDIT REVIEW The report is based on the financial statements which have been reviewed by Nexia Perth Audit Services Pty Ltd. ATTACHMENTS Refer to the Directors’ Report for an explanation of the operational and financial results of the Company. CONTENTS Corporate Directory Directors' Report Auditor’
Earlier from Blinklab
- Quarterly Activities/Appendix 4C Cash Flow Report
- High-Profile Journal Publication Validates BB1 Technology
- Appointment of Managing Director and Board Changes
- Pilot Study Confirms High Diagnostic Accuracy & Readiness
- 2025 Annual Report & Appendix 4E
Later from Blinklab
- Clinical Trial Network for Pivotal FDA Study Complete
- Trading Halt
- Morocco's Nationwide Government-Funded Autism Screening
- Validation Program Commences-FDA 510(k) - First Participant
- BlinkLab Launches Pivotal US FDA Trial for AI Smartphone Autism Diagnostic
Follow Blinklab into a list and get an email when it puts out news.
Follow Blinklab